Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner J Geldenhuys

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 24, 2010
3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonistsWerner J Geldenhuys, Hiroshi Nakamura
Bioorganic & Medicinal Chemistry Letters|March 12, 2021
Development of an a priori computational approach for brain uptake of compounds in an insect model systemWerner J Geldenhuys, Jeffrey R Bloomquist
Life Sciences|August 30, 2005
Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous systemDavid D Allen, Werner J Geldenhuys
Central Nervous System Agents in Medicinal Chemistry|April 10, 2012
The blood-brain barrier choline transporterWerner J Geldenhuys, David D Allen
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptorWerner J Geldenhuys, Mark A Simmons
Expert Review of Neurotherapeutics|December 9, 2014
Pharmacotherapy of Alzheimer's disease: current and future trendsWerner J Geldenhuys, Altaf S Darvesh
Journal of Chromatographic Science|February 17, 2012
Development and validation of a novel RP-HPLC method for the analysis of reduced glutathioneVijaykumar Sutariya, Daniel Wehrung, Werner J Geldenhuys
Bioorganic & Medicinal Chemistry Letters|April 8, 2014
A novel Lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4)Werner J Geldenhuys, Danielle Aring, Prabodh Sadana
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|November 8, 2021
Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a <i>C. elegans</i> model of Parkinson's diseaseJacob Boos, Ahmed Shubbar, Werner J Geldenhuys
International Journal of Pharmaceutics|February 1, 2020
Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injuryPushkar Saralkar, Tasneem Arsiwala, Werner J Geldenhuys
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|February 24, 2010
3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonistsWerner J Geldenhuys, Hiroshi Nakamura
Bioorganic & Medicinal Chemistry Letters|March 12, 2021
Development of an a priori computational approach for brain uptake of compounds in an insect model systemWerner J Geldenhuys, Jeffrey R Bloomquist
Life Sciences|August 30, 2005
Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous systemDavid D Allen, Werner J Geldenhuys
Central Nervous System Agents in Medicinal Chemistry|April 10, 2012
The blood-brain barrier choline transporterWerner J Geldenhuys, David D Allen
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptorWerner J Geldenhuys, Mark A Simmons
Expert Review of Neurotherapeutics|December 9, 2014
Pharmacotherapy of Alzheimer's disease: current and future trendsWerner J Geldenhuys, Altaf S Darvesh
Journal of Chromatographic Science|February 17, 2012
Development and validation of a novel RP-HPLC method for the analysis of reduced glutathioneVijaykumar Sutariya, Daniel Wehrung, Werner J Geldenhuys
Bioorganic & Medicinal Chemistry Letters|April 8, 2014
A novel Lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4)Werner J Geldenhuys, Danielle Aring, Prabodh Sadana
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|November 8, 2021
Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a <i>C. elegans</i> model of Parkinson's diseaseJacob Boos, Ahmed Shubbar, Werner J Geldenhuys
International Journal of Pharmaceutics|February 1, 2020
Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injuryPushkar Saralkar, Tasneem Arsiwala, Werner J Geldenhuys
Pageof 16